(2012) Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease. Neurobiology of Aging, Vol.33 (No.3). pp. 457-465. ISSN 0197-4580

Full text not available from this repository.

Abstract

Replications of the association between APOE-ε4 allele load and regional brain atrophy in Alzheimer's disease (AD) patients hold promise for future studies testing relationships between other disease risk gene variants and brain structure. A polymorphism, rs10868366, in the Golgi phosphoprotein 2 gene, GOLM1, was recently identified as an AD risk factor in a genome-wide association study. In a subset of the same AD cohort, we used voxel-based morphometry to test for association between the disease risk genotype and reduced regional gray matter (GM) volume in AD patients (n = 72). A mean 14% reduction in GM volume was observed in the left frontal gyrus with the higher risk GG genotype. A similar association was observed in an independent, dataset of nondemented subjects (n = 278), although with a smaller effect (1%). This replicated association with GM structural variation suggests that GOLM1 polymorphisms may be related to cognitive phenotypes. The greater effect size in AD patients also suggests that the GG genotype could be a risk factor for the expression of cognitive deficits in AD.

Item Type:	Submitted Journal Article
Subjects:	Q Science > QP Physiology R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Divisions:	Faculty of Science > Statistics Faculty of Medicine > Warwick Medical School Faculty of Science > WMG (Formerly the Warwick Manufacturing Group)
Library of Congress Subject Headings (LCSH):	Prefrontal cortex, Alzheimer's disease, Brain -- Degeneration
Journal or Publication Title:	Neurobiology of Aging
Publisher:	Elsevier Inc.
ISSN:	0197-4580
Date:	March 2012
Volume:	Vol.33
Number:	No.3
Number of Pages:	19
Page Range:	pp. 457-465
Identification Number:	10.1016/j.neurobiolaging.2010.04.018
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Funder:	GlaxoSmithKline
References:	Allen Brain Atlas, available at: www.brain-map.org. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. American Psychiatric Association, Washington, DC. Antúnez, C., Boada, M., López-Arrieta, J., Ramirez-Lorca, R., Hernández, I., Marín, J., Martínez-Lage, P., González-Pérez, A., Jorge Galan, J., Gayán, J., Real, L.M., Ruiz, A., 2009. GOLPH2 gene markers are not associated with Alzheimer’s disease in a sample of the Spanish population. J. Alzheimers Dis. 18, 751–754. Bachert, C., Fimmel, C., Linstedt, A.D., 2007. Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic 8, 1415–1423. Badre, D., Wagner, A.D., 2007. Left ventrolateral prefrontal cortex and the cognitive control of memory. Neuropsychologia 45, 2883–2901. Barnes, J., Bartlett, J.W., van de Pol, L.A., Loy, C.T., Scahill, R.I., Frost, C., Thompson, P., Fox, N.C., 2009. A meta-analysis of hippocampal atrophy rates in Alzheimer’s disease. Neurobiol. Aging 30, 1711–1723. Barrett, J.C., Fry, B., Maller, J., Daly, M.J., 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265. Blacker, D., Bertram, L., Saunders, A.J., Moscarillo, T.J., Albert, M.S., Wiener, H., Perry, R.T., Collins, J.S., Harrell, L.E., Go, R.C., Mahoney, A., Beaty, T., Fallin, M.D., Avramopoulos, D., Chase, G.A., Folstein, M.F., McInnis, M.G., Bassett, S.S., Doheny, K.J., Pugh, E.W., Tanzi, R.E., NIMH Genetics Initiative Alzheimer’s Disease Study Group, 2003. Results of a high-resolution genome screen of 437 Alzheimer’s disease families. Hum. Mol. Genet. 12, 23–32. Boccardi, M., Sabattoli, F., Testa, C., Beltramello, A., Soininen, H., Frisoni, G.B., 2004. APOE and modulation of Alzheimer’s and frontotemporal dementia. Neurosci. Lett. 356, 167–170. Chan, D., Janssen, J.C., Whitwell, J.L., Watt, H.C., Jenkins, R., Frost, C., Rossor, M.N., Fox, N.C., 2003. Change in rates of cerebral atrophy over time in early-onset Alzheimer’s disease: longitudinal MRI study. Lancet 362, 1121–1122. Curtis, D., North, B.V., Sham, P.C., 2001. A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer’s disease. Ann. Hum. Genet. 65 (Pt 5), 473–481. Filippini, N., Rao, A., Wetten, S., Gibson, R.A., Borrie, M., Guzman, D., Kertesz, A., Loy-English, I., Williams, J., Nichols, T., Whitcher, B., Matthews, P.M., 2009. Anatomically-distinct genetic associations of Apoe e4 allele load with regional cortical atrophy in Alzheimer’s disease. Neuroimage 44, 724–728. Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198. Geroldi, C., Pihlajamaki, M., Laakso, M.P., deCarli, C., Beltramello, A., Bianchetti, A., Soininen, H., Trabucchi, M., Frisoni, G.B., 1999. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53, 1825–1832. Good, C.D., Johnsrude, I.S., Ashburner, J., Henson, R.N., Friston, K.J., Frackowiak, R.S., 2001. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14, 21–36. Hashimoto, M., Yasuda, M., Tanimukai, S., Matsui, M., Hirono, N., Kazui, H., Mori, E., 2001. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer’s disease. Neurology 57, 1461– 1466. Hayasaka, S., Phan, K.L., Liberzon, I., Worsley, K.J., Nichols, T.E., 2004. Nonstationary cluster- size inference with random field and permutation methods. Neuroimage 22, 676–687. Holmans, P., Hamshere, M., Hollingworth, P., Rice, F., Tunstall, N., Jones, S., Moore, P., Wavrant DeVrieze, F., Myers, A., Crooks, R., Compton, D., Marshall, H., Meyer, D., Shears, S., Booth, J., Ramic, D., Williams, N., Norton, N., Abraham, R., Kehoe, P., Williams, H., Rudrasingham, V., O’Donovan, M., Jones, L., Hardy, J., Goate, A., Lovestaone, S., Owen, M., Williams, J., 2005. Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer’s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 135B, 24–32. Hu, Z., Zeng, L., Huang, Z., Zhang, J., Li, T., 2007. The study of golgi apparatus in alzheimer’s disease. Neurochem. Res. 32, 1265–1277. Inkster, B., Nichols, T.E., Saemann, P.G., Auer, D.P., Holsboer, F., Muglia, P., Matthews, P.M., 2009. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch. Gen. Psychiatry 66, 721–728. Ioannidis, J.P., Trikalinos, T.A., Khoury, M.J., 2006. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am. J. Epidemiol. 164, 609–614. Jack, C.R., Jr, Petersen, R.C., Xu, Y., O’Brien, P.C., Smith, G.E., Ivnik, R.J., Boeve, B.F., Tangalos, E.G., Kokmen, E., 2000. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484–489. Judas, M., Cepanec, M., 2007. Adult structure and development of the human fronto-opercular cerebral cortex (Broca’s region). Clin. Linguist. Phon. 21, 975–989. Kladney, R.D., Bulla, G.A., Guo, L., Mason, A.L., Tollefson, A.E., Simon, D.J., Koutoubi, Z., Fimmel, C.J., 2000. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 249, 53–65. Lee, J.H., Cheng, R., Santana, V., Williamson, J., Lantigua, R., Medrano, M., Arriaga, A., Stern, Y., Tycko, B., Rogaeva, E., Wakutani, Y., Kawarai, T., St George-Hyslop, P., Mayeux, R., 2006. Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease. Arch. Neurol. 63, 1591–1598. Lehtovirta, M., Laakso, M.P., Soininen, H., Helisalmi, S., Mannermaa, A., Helkala, E.L., Partanen, K., Ryynanen, M., Vainio, P., Hartikainen, P., et al., 1995. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 67, 65–72. Lehtovirta, M., Soininen, H., Laakso, M.P., Partanen, K., Helisalmi, S., Mannermaa, A., Ryynanen, M., Kuikka, J., Hartikainen, P., Riekkinen, P.J. Sr., 1996. SPECT and MRI analysis in Alzheimer’s disease: relation to apolipoprotein E epsilon 4 allele. J. Neurol. Neurosurg. Psychiatry 60, 644–649. Li, H., Wetten, S., Li, L., St. Jean, P.L., Upmanyu, R., Surh, L., Hosford, D., Barnes, M.R., Briley, J.D., Borrie, M., Coletta, N., Delisle, R., Dhalla, D., Ehm, M.G., Feldman, H.H., Fornazzari, L., Gauthier, S., Goodgame, N., Guzman, D., Hammond, S., Hollingworth, P., Hsiung, G.Y., Johnson, J., Kelly, D.D., Keren, R., Kertesz, A., King, K.S., Lovestone, S., Loy-English, I., Matthews, P.M., Owen, M.J., Plumpton, M., Pryse-Phillips, W., Prinjha, R.K., Richardson, J.C., Saunders, A., Slater, A.J., St. George-Hyslop, P.H., Stinnett, S.W., Swartz, J.E., Taylor, R.L., Wherrett, J., Williams, J., Yarnall, D.P., Gibson, R.A., Irizarry, M.C., Middleton, L.T., Roses, A.D., 2008. Candidate singlenucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol. 65, 45–53. McDonalds, C.R., McEvoy, L.K., Gharapetian, L., Fennema-Notestine, C., Hagler, D.J., Jr, Holland, D., Koyama, A., Brewer, J.B., Dale, A.M., Alzheimer’s Disease Neuroimaging Initiative, 2009. Regional rates of neocortical atrophy from normal aging to Alzheimer’s disease. Neurology 73, 457–465. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., 1984. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34, 939–944. Mudge, J., Miller, N.A., Khrebtukova, I., Lindquist, I.E., May, G.D., Huntley, J.J., Luo, S., Zhang, L., van Velkinburgh, J.C., Farmer, A.D., Lewis, S., Beavis, W.D., Schilkey, F.D., Virk, S.M., Black, C.F., Myers, M.K., Mader, L.C., Langley, R.J., Utsey, J.P., Kim, R.W., Roberts, R.C., Khalsa, S.K., Garcia, M., Ambriz-Griffith, V., Harlan, R., Czika, W., Martin, S., Wolfinger, R.D., Perrone-Bizzozero, N.I., Schroth, G.P., Kingsmore, S.F., 2008. Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One 3, e3625. Muglia, P., Tozzi, F., Galwey, N.W., Francks, C., Upmanyu, R., Kong, X.Q., Antoniades, A., Domenici, E., Perry, J., Rothen, S., Vandeleur, C.L., Mooser, V., Waeber, G., Vollenweider, P., Preisig, M., Lucae, S., Müller-Myhsok, B., Holsboer, F., Middleton, L.T., Roses, A.D., 2008. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol. Psychiatry, in press. PMID: 19107115. Myers, A., Wavrant De-Vrieze, F., Holmans, P., Hamshere, M., Crook, R., Compton, D., Marshall, H., Meyer, D., Shears, S., Booth, J., Ramic, D., Knowles, H., Morris, J.C., Williams, N., Norton, N., Abraham, R., Kehoe, P., Williams, H., Rudrasingham, V., Rice, F., Giles, P., Tunstall, N., Jones, L., Lovestone, S., Williams, J., Owen, M.J., Hardy, J., Goate, A., 2002. Full genome screen for Alzheimer disease: stage II analysis. Am. J. Med. Genet. 114, 235–244. Nichols, T., Hayasaka, S., 2003. Controlling the familywise error rate in functional neuroimaging: a comparative review. Stat. Methods Med. Res. 12, 419–446. Olson, J.M., Goddard, K.A., Dudek, D.M., 2002. A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am. J. Hum. Genet. 71, 154–161. Pericak-Vance, M.A., Grubber, J., Bailey, L.R., Hedges, D., West, S., Santoro, L., Kemmerer, B., Hall, J.L., Saunders, A.M., Roses, A.D., Small, G.W., Scott, W.K., Conneally, P.M., Vance, J.M., Haines, J.L., 2000. Identification of novel genes in late-onset Alzheimer’s disease. Exp. Gerontol. 35, 1343–1352. Puri, S., Bachert, C., Fimmel, C.J., Linstedt, A.D., 2002. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 3, 641–653. Schjeide, B.M., Hooli, B., Parkinson, M., Hogan, M.F., DiVito, J., Mullin, K., Blacker, D., Tanzi, R.E., Bertram, L., 2009. GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results. Arch. Neurol. 66, 250–254. Su, A.I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K.A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., Cooke, M.P., Walker, J.R., Hogenesch, J.B., 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U. S. A. 101, 6062–6067. Tanaka, S., Kawamata, J., Shimohama, S., Akaki, H., Akiguchi, I., Kimura, J., Ueda, K., 1998. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer’s disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies. Dement. Geriatr. Cogn. Disord. 9, 90–98. Thompson, P.M., Hayashi, K.M., Dutton, R.A., Chiang, M.C., Leow, A.D., Sowell, E.R., De Zubicaray, G., Becker, J.T., Lopez, O.L., Aizenstein, H.J., Toga, A.W., 2007. Tracking Alzheimer’s disease. Ann. N.Y. Acad. Sci. 1097, 183–214. Tozzi, F., Prokopenko, I., Perry, J.D., Kennedy, J.L., McCarthy, A.D., Holsboer, F., Berrettini, W., Middleton, L.T., Chilcoat, H.D., Muglia, P., 2008. Family history of depression is associated with younger age of onset in patients with recurrent depression. Psychol. Med. 38, 641– 649. Tzourio-Mazoyer, N., Landbeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., Joliot, M., 2002. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273–289.
URI:	http://wrap.warwick.ac.uk/id/eprint/41130

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item